TransMedics’ Organ Tech Promises 22% Upside
TransMedics revolutionizes the $8B organ transplant market with its OCS, projecting significant revenue growth and profitability.
- Latest
- Trending
TransMedics revolutionizes the $8B organ transplant market with its OCS, projecting significant revenue growth and profitability.
Sonida Senior Living reports a historic 86.2% occupancy rate and 8.4% revenue growth for Q2 2024.
Mercari reports 9% revenue growth in FY'24. Eyes fintech expansion and targets double-digit growth.
Explore Oracle's AI opportunity, stock performance, and strategic growth in the evolving AI landscape.
Chartwell achieved robust Q2 financial results, expanding occupancy and operating margin, with strategic acquisitions in Quebec.
Fossil reports mixed Q2 2024 results; maintains $1.2B forecast, aims for financial stability amid strategic shifts.
Starbucks shares climb 2.7% as activist Starboard invests. Stake size unknown, follows Elliot's recent involvement.
Bio-Techne shows resilience with strategic growth in diagnostics despite fiscal year challenges and market declines.
Fortinet shares soared after posting record operating margins and strong earnings, leading S&P 500 gainers.
ACM Research targets $3 billion revenue, boosts 2024 outlook amid robust Q2 growth and strategic expansions.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.